Merck Launches H3N2 Canine Flu Vaccine
November 20, 2015
Merck Animal Health today matched competitor Zoetis Inc. with the release of a dog flu vaccine that protects against the new H3N2 strain. Merck, based in Madison, N.J., received a conditional license from the U.S. Department of Agriculture for Canine Influenza Vaccine, H3N2, Killed Virus. Zoetis announced the same achievement, the first company to do… Continue reading...